logomap中文|EN

A Global Foot Print

Phagelux AgriHealth

Phagelux AgriHealth utilizes phages, other biologics, and related or enabling technologies to create novel antibacterial products and solutions. These products address bacterial problems across multiple segments of agriculture, particularly targeting antibiotic resistant strains of bacteria. Phagelux AgriHealth has research labs and manufacturing facilities in North America and China. The Company aims to be a leading global Bio-agricultural company.

Phagelux AgriHealth has four franchises: crop sciences, animal health, food safety and feed additives. The Company currently sells four crop sciences products, three food safety products and five animal health products (not all products available in all markets yet). Additional products are in development or under regulatory review.

Phagelux AgriHealth

Management

Tyler Homer

Tyler Homer

COO of OmniLytics

MBA. Experienced in regulatory, production and operations for phage products.

Dr. Ryan Bringhurst

Dr. Ryan Bringhurst

VP, Agricultural Research

Ph.D in Microbiology. 10 years developing phage products, with focus on food safety and treatment of agricultural diseases.

Dr. Xuling Xu

Dr. Xuling Xu

Technical Director

Ph.D in Molecular biology. 7 years experience in managing phage product development.

Dr. Yu Cong

Dr. Yu Cong

Technical Director

Ph.D in Agronomy. Strong expertise in horticultural science and plant nutrition.

Ryan Benson

Ryan Benson

Director of Sales and Marketing - US

Extensive experience in agricultural sales and market management.

History

2013.11

Founded and invested by the Management and Wuxi AppTec.

2014.2

First research lab established in Nanjing.

2015.7

Acquisition of Omnilytics, to obtain R&D and production capacity in North America and to start to implement a global strategy

2016.1

Round A financing completed.

2018.7

Round B financing completed.

2019.10

Spun off from Phagelux HumanHealth.

2020.6

Bring in strategic investor Wuxi Guolian.

icon
icon

R&D Centers

  • R&D Center in Nanjing, China
    R&D Center in Nanjing, China
    R&D Center in Nanjing, China

    R&D Center in Nanjing, China

    1,500 SM facility, which includes small scale manufacturing facility. 6 products from this facility have already been registered in China, and another 8 are under development or regulatory review. The facility is primarily working on phages for animal health, including disinfectants, feeds and medicines.
  • R&D Center in SLC, Utah
    R&D Center in SLC, Utah
    R&D Center in SLC, Utah

    R&D Center in SLC, Utah

    750 SM research lab including Biosafety Level 2 Laboratory, with large private library of characterized phages and bacteria. The facility is primarily working on the development of crop science and food safety products and currently working on 8 new products and supporting 7 established products.